Related Experiment Video
Updated: Jun 9, 2026

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
APOE and cholesterol homeostasis in Alzheimer's disease
Valérie Leduc1, Stéphanie Jasmin-Bélanger, Judes Poirier
1Douglas Mental Health University Institute, 6875 Lasalle, Montreal (Verdun), Quebec, H4H 1R3, Canada.
Abstract:
Converging evidence from clinical and pathological studies indicate the presence of important relationships between the ongoing deterioration of brain lipid homeostasis, vascular changes and the pathophysiology of sporadic Alzheimer's disease (AD). These associations include the recognition of cholesterol transporters apolipoprotein E (APOE), APOC1 and APOJ as major genetic risk factors for common AD and observations associating risk factors for cardiovascular disease such as high midlife plasma cholesterol, diabetes, stroke, obesity and hypertension to dementia. Moreover, recent clinical findings lend support to the notion that progressive deterioration of cholesterol homeostasis in AD is a central player in the disease pathophysiology and is, therefore, a potential therapeutic target for disease prevention.
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Cholesterol: Significance and Regulation
Considering cholesterol and...
Alzheimer's Disease: Treatment
Atherosclerosis I: Introduction

